BMC Cancer

official impact factor 3.15

Open Access

A polymorphism at the 3'-UTR region of the aromatase gene defines a subgroup of postmenopausal breast cancer patients with poor response to neoadjuvant letrozole

Zaida Garcia-Casado, Angel Guerrero-Zotano, Antonio Llombart-Cussac, Ana Calatrava, Antonio Fernandez-Serra, Amparo Ruiz-Simon, Joaquin Gavila, Miguel A Climent, Sergio Almenar, Jose Cervera-Deval, Josefina Campos, Carlos V Albaladejo, Antonio Llombart-Bosch, Vicente Guillem and Jose A Lopez-Guerrero*

  • * Corresponding author: Jose A Lopez-Guerrero jalopez@fivo.org

  • † Equal contributors

BMC Cancer 2010, 10:36 doi:10.1186/1471-2407-10-36

Accesses  

  • Last 30 days: 63 accesses
  • Last 365 days: 766 accesses
  • All time: 2192 accesses

Cited by

BioMed Central: 1 citation

Review   Subscription

Understanding the mechanisms of aromatase inhibitor resistance

William R Miller, Alexey A Larionov Breast Cancer Research 2012, 14:201 (19 January 2012)